Overexpression of a putative type III polyketide synthase (PKSIII) from the marine myxobacterium Enhygromyxa salina SWB007 in Streptomyces coelicolor M1146 led to the accumulation of a novel monoketopiperazine consisting of phenylalanine and isoleucine. This compound was named phileucin and shows high structural similarity to phevalin (aureusimine B). The protease inhibiting activity was tested against human cathepsin L, human leukocyte elastase, bovine trypsin and bovine chymotrypsin. In contrast to phevalin, no protease inhibition was observed.
Marine myxobacteria, e.g. of the genus Enhygromyxa, have the potential to biosynthesize so far unknown natural products [1] . For E. salina SWB007 production of enhygrolides and of salimabromide (1) was shown ( Figure 1) [2, 3] . Compound 1 is a brominated polyketide with an unprecedented carbon skeleton, which exhibited moderate antibiotic activity against Gram-positive bacteria. However, the biosynthesis of salimabromide (1) remained elusive up to now. The structure of 1 gives hints towards the involvement of a polyketide synthase (PKS), a terpene synthase, and a halogenase. Thus, a putative type III PKS identified within the genome of E. salina SWB007, which is clustered with a putative halogenase, should be tested towards its involvement in the biosynthesis. For this purpose, the corresponding gene named ks007 was heterologously expressed in Streptomyces coelicolor M1146 [4] . Using the vector pGM1202 (kindly provided by Dr Günther Muth, University of Tübingen, Germany), the expression of ks007 was inducible under the control of the tipA promoter. The identity of the construct pGM1202-ks007 was verified by sequencing, and it was transferred to S. coelicolor M1146 by bi-parental conjugation, yielding strain S. coelicolor M1146 pGM1202-ks007. Cells of this strain were grown in ISP2 medium and the expression of the gene ks007 was induced by adding thiostreptone to the culture. After seven days of incubation, the cultures were extracted using ethyl acetate. Analysis of the resulting crude extract by chromatographic methods revealed one additional peak in comparison to the host strain. To elucidate the identity of the metabolite causing the additional peak, the compound was purified by vacuum liquid chromatography (VLC) and high performance liquid chromatography (HPLC).
Following purification, the molecular formula of compound 2 ( (Table 1) disclosed 15 resonances resulting from two methyl groups (δ c 12.3 for C-1, δ c 18.3 for C-4), two sp 3 methylene groups (δ c 28.7 for C-2, δ c 37.1 for C-9), six sp 2 methine groups (δ c 123.5 for C-8, δ c 129.9 for C-11, δ c 129.9 for C-12, δ c 128.2 for C-13, δ c 129.9 for C-14, δ c 129.9 for C-15), one sp 3 methine group (δ c 37.6 for C-3) and four sp 2 quaternary carbon atoms (δ c 161.5 for C-5, δ c 158.5 for C-6, into an aromatic ring system. The aromatic ring system was indicated by the UV spectrum, revealing an absorption band with a maximum at 328 nm ( Figure S1 ).
The planar structure of compound 2 as shown in Figure 1 was deduced from 1 H-1 H COSY and 1 H-13 C HMBC measurements. The COSY spectrum showed two independent spin systems: (i) one aromatic part from H-11 to H-15, and (ii) one smaller alkyl part from H 3 -1 to H 3 -4. The HMBC spectrum further reveals the coupling between H-3 and both C-5 and C-6, indicating a branched alkyl moiety. HMBC correlations between H 2 -9 and all C-11, C-15, C-7 and C-8 delineated the presence of a phenylalanine derived moiety. However, the connection between both moieties could not be easily observed. A closer look at the HMBC spectrum revealed a very weak coupling between H-8 and C-5, indicating their connection via a nitrogen atom, evidenced by the chemical shift of carbon C-5 (Table 1) . Taking the molecular formula and the chemical shifts of C-6 and C-7 into account, their connection via a peptide bond was deduced, completing the planar structure of compound 2. Due to the low amount of isolated substance, it was not possible to identify the stereochemistry of phileucin at C-3.
Unexpectedly, the isolated compound was not a polyketide, and thus not the product of the heterologously expressed PKSIII. Instead, structural analysis revealed a 3,6-disubstituted 2(1H)pyrazinone, a compound which can be considered as dehydrated diketopiperazine, deduced from the amino acids phenylalanine and isoleucine. We suggest the name phileucin (2). The mechanism underlying the production of 2, due to the expression of the putative PKSIII gene from E. salina SWB007, is unknown. Compound 2 bears strong resemblance to phevalin (3, also known as aureusimine B), which was reported to have calpain inhibiting properties (IC 50 1.3 µM) [5] . However, this finding was not confirmed with a synthetic sample of phevalin [6] . Phevalin and the structurally related tyrvalin were found in Staphylococcus aureus strains and are suspected to be involved in biofilm formation [7] .
Moreover, the structurally related 2(1H)-pyrazinone derivative M926 (4) (Figure 1 ) potently inhibited caspase-3 [8] . In the light of the reported protease inhibiting properties of 3 and 4, compound 2 was evaluated for inhibiting activities towards clinically relevant proteases. The selected enzymes were human cathepsin L, a cysteine protease, as well as the serine proteases human leukocyte elastase, bovine trypsin and bovine chymotrypsin. However, phileucin (2) showed no significant inhibitory activity towards any of the enzymes tested; all IC 50 values were above 100 µM.
Experimental

Construction of strain S. coelicolor M1146 pGM1202-KS007:
The putative ketosynthase gene ks007 was amplified by colony-PCR, using E. salina SWB007 cells with the following primers: forwardprimer containing an NdeI restriction-site (KS007-for: GCGCATATGTCAACCGTCATCCCCGTTGGTATT), and reverse-primer containing a HindIII restriction-site (KS007-rev: GGCAAGCTTCAGCGGCTCGAAGAAAAGAAGTAG). PCR reactions were analysed by agarose gel electrophoresis on a 1% agarose gel. The expected band with a size of 1139 bp was excised and the DNA was purified using the Promega SV Gel and PCR clean up system, and ligated into the pGEM-T vector (Promega). The construct was transferred into chemically competent E. coli XL1 Blue cells by heat-shock transformation. Candidate colonies were grown in liquid LB amp medium for 16 h at 37°C and plasmids were isolated using Promega Pure yield Miniprep Kit. Restriction of the plasmids with NdeI and HindIII verified the presence of the target gene ks007. A plasmid harbouring the ks007 was chosen and the identity of the insert was verified by sequencing with T7 and SP6 primers (GATC Biotech). Subsequently, the ks007 gene was transferred into pGM1202 (NdeI, HindIII) by ligation for 16 h at 4°C. The resulting plasmid pGM1202-ks007 was transferred into competent E. coli ET12567 pUZ8002 cells using heat-shock transformation, resulting in the strain E. coli ET12567 pUZ8002 pGM1202-ks007.
The pGM1202-ks007 plasmid was transferred to S. coelicolor M1146 by conjugation between E. coli ET12567 pUZ8002 pGM1202-ks007 and S. coelicolor M1146. For the conjugation, ET12567 pUZ8002 pGM1202-ks007 cells were grown in 100 mL LB apra/kan -medium at 37°C up to an OD 600 of 0.5. The cells were then precipitated at 10000 rcf for 10 min and the resulting cell pellet washed twice in 10 mL LB-medium. The pellet was resuspended in 1 mL LB-medium. Meanwhile, 10 µL of S. coelicolor M1146 spore solution was added to 500 µL 2xYT broth (16 g/L tryptone, 10 g/L yeast extract, 5 g/L NaCl, pH 7.0) and heat shocked at 50°C for 10 min. After cooling to room temperature, 500 µL of E. coli ET12567 pUZ8002 pGM1202-ks007 suspension was added. The mixture was precipitated at 10000 rcf for 3 min and resuspended in the return flow. The resulting suspension was transferred to Cullum-medium agar plates (mannitol 20 g/L, soy-flour 20 g/L, agar 20 g/L, pH 7.3) containing 10 mM MgCl 2 and incubated at 30°C for 16 h. Subsequently, 1 mL nalidixic-acid solution (60 mg/mL in CH 3 Cl) and 1 mL apramycin solution (100 mg/mL) were applied to the plates and allowed to set into the agar. The plates were incubated at 30°C for one week until colonies became visible. The visible colonies were transferred to Cullum-plates containing 60 µg/mL nalidixic acid and 100 µg/mL apramycin for selection, and were incubated for 5 days at 30°C. The presence of the ks007 gene was verified by colony-PCR of the candidate colonies using the KS007for and KS007-rev primers.
Isolation and purification of phileucin: S. coelicolor M1146 pGM1202-ks007 was cultivated on a larger scale using 1 L of ISP2 medium (10 g/L malt extract, 4 g/L yeast extract, 4 g/L glucose, pH 7.5) containing 0.5 mg/L apramycin at 30°C, with a 120 rpm shaking speed. The expression of the gene was induced twice, once after 3 days and then after 5 days of incubation, by the addition of 0.05 mg/L thiostreptone. After 7 days the culture was extracted 2 times by liquid/liquid phase extraction using an equal amount of ethyl acetate. 
Enzymatic assays:
The proteases were assayed as described [9, 10] .
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